跳至主要内容
临床试验/EUCTR2017-003003-22-DK
EUCTR2017-003003-22-DK进行中(未招募)1 期

postoperative effect of optimal multimodal pain management supplemented with systemic single dose of Dexamethason in the first week after UKA. Low dose (8mg) or mean dose

Aalborg University Hospital, Department of Orthopedics0 个研究点目标入组 70 人开始时间: 2017年10月10日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • patients < 18 years scheduled for UKA
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 35
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 35

排除标准

  • Fertil women, daily use of opioids, NSAID or glucocorticoid, allergi to medicin used in the trial,alcohol abuse, cognictive dysfunction, severe kidney or hesrt disease, language barrier, operation in generel anaesthesia

研究者

发起方
Aalborg University Hospital, Department of Orthopedics

相似试验